Savara, Inc.
SVRA
|
$5.06
-0.2%
-0.2%
1.9M
|
Health Technology
(0.0% 1d) (7.0% 1m) (186.4% 1y) (0.0% 2d) (0.0% 3d) (6.3% 7d) (58.04% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 699,029,593
http://www.savarapharma.com
Sec Filling | Patents | 39 employees
(US) Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.
respiratory treatment respiratory diseases
add to watch list Paper trade email alert is off
Press-releases
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: -2.3%
conference international
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 1.29%
H: 2.09%
C: 1.82%
business update financial results
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
Published: 2024-03-06 (Crawled : 22:00) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 0.37%
H: 0.46%
C: -0.55%
conference global
Savara Announces New Employment Inducement Grant - February 2, 2024
Published: 2024-02-02 (Crawled : 14:30) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: -1.38%
H: 2.18%
C: -2.81%
grant
Savara to Present at Two Upcoming Healthcare Conferences
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: -0.2%
H: 2.28%
C: -1.98%
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-21 (Crawled : 19:00) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: -0.8%
H: 3.49%
C: 0.27%
conference
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
SLNO 4 | $38.52 3.72% 3.58% 290K
|
Health Technology
|
| O: -2.42%
H: 5.41%
C: 2.0%
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 1.91%
H: 2.01%
C: 0.54%
update therapeutics financial results
Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
SLNO 4 | $38.52 3.72% 3.58% 290K
|
Health Technology
|
| O: -0.66%
H: 2.45%
C: 0.22%
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 0.26%
H: 0.26%
C: -8.27%
INSM | $26.83 -1.54% -1.57% 2M
|
Health Technology
|
| O: -0.4%
H: 2.5%
C: 0.49%
therapeutics
Savara Reports Second Quarter Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 00:00) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 0.81%
H: 5.33%
C: 2.4%
business update financial results
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Published: 2023-07-13 (Crawled : 13:00) - biospace.com/
SVRA | $5.06 -0.2% -0.2% 1.9M
|
Health Technology
|
| O: 7.74%
H: 7.66%
C: 1.09%
offering
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Last 48 Hours Insiders Buying
RMCF | $3.56 -7.2% 7.1K
|
Consumer Non-Durables
|
20:10